Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Targeting Intensive Glycaemic Control Versus Targeting Conventional Glycaemic Control for Type 2 Diabetes Mellitus." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457513/all/images/google-play-badge.png.
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457513/all/images/google-play-badge.png. Accessed May 2, 2024.
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457513/all/images/google-play-badge.png
Targeting Intensive Glycaemic Control Versus Targeting Conventional Glycaemic Control for Type 2 Diabetes Mellitus [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457513/all/images/google-play-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
ID - 457513
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457513/all/images/google-play-badge.png
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -